Follicular Output Rate and Follicle-to-Oocyte Index of Low Prognosis Patients According to POSEIDON Criteria: A Retrospective Cohort Study of 32,128 Treatment Cycles

被引:22
作者
Chen, Lijuan [1 ]
Wang, Hui [1 ]
Zhou, Hanying [1 ]
Bai, Haiyan [1 ]
Wang, Tao [1 ]
Shi, Wenhao [1 ]
Shi, Juanzi [1 ]
机构
[1] Xi An Jiao Tong Univ, Northwest Womens & Childrens Hosp, Assisted Reprod Ctr, Xian, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2020年 / 11卷
关键词
POSEIDON; low prognosis patient; ovarian sensitivity; follicular output rate; follicle-to-oocyte index; ASSISTED REPRODUCTIVE TECHNOLOGY; IN-VITRO FERTILIZATION; OVARIAN STIMULATION; IVF/ICSI; COULD;
D O I
10.3389/fendo.2020.00181
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To investigate ovarian sensitivity in subgroups of patients with a low prognosis, as defined by the POSEIDON criteria, undergoing in vitro fertilization treatment and measures to improve ovarian sensitivity in these patients. Design We conducted a retrospective cohort analysis. Setting The study was conducted at an IVF clinic in a public hospital. Patients A total of 32,128 fresh IVF cycles from January 2014 to October 2018 at a single IVF clinic were included in the analysis. Patients with a low prognosis were categorized into four groups based on the POSEIDON criteria. Interventions None. Main Outcome Measure The primary outcome measures were the follicular output rate (FORT) and the follicle-to-oocyte index (FOI). Results The FORTs in the order from the highest to the lowest were 1.18 in group 3, 0.98 in group 4, 0.76 in group 1, and 0.68 in group 2. The trend in the FOI values was consistent with that in the FORTs. Among patients with poor ovarian sensitivity, 58.41% of patients with FORTs >= 0.30 in the second cycle underwent an adjustment to the ovarian stimulation (OS) protocol and 41.59% underwent an adjustment to the gonadotropin (Gn) starting dose. Among patients with normal ovarian sensitivity, 43.56% of those with FORTs >= 0.80 in the second cycle underwent an adjustment to the OS protocol and 56.44% underwent an adjustment to the Gn starting dose. Conclusion Ovarian sensitivity was the highest in group 3 (young women with poor ovarian reserve), followed by groups 4 (women at advanced age with poor ovarian reserve) and 1 (young women with good ovarian reserve), and it was the lowest in group 2 (women at advanced age with good ovarian reserve). For patients with poor ovarian sensitivity, it is preferred to recommend an adjustment to the OS protocol, while for those with normal ovarian sensitivity, adjusting the Gn starting dose is preferred.
引用
收藏
页数:11
相关论文
共 24 条
  • [1] Oxidative stress and its implications in female infertility - a clinician's perspective
    Agarwal, A
    Gupta, S
    Sharma, R
    [J]. REPRODUCTIVE BIOMEDICINE ONLINE, 2005, 11 (05) : 641 - 650
  • [2] Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker-The Follicle-To-Oocyte (FOI) Index
    Alviggi, Carlo
    Conforti, Alessandro
    Esteves, Sandro C.
    Vallone, Roberta
    Venturella, Roberta
    Staiano, Sonia
    Castaldo, Emanuele
    Andersen, Claus Yding
    De Placido, Giuseppe
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2018, 9
  • [3] Clinical relevance of genetic variants of gonadotrophins and their receptors in controlled ovarian stimulation: a systematic review and meta-analysis
    Alviggi, Carlo
    Conforti, Alessandro
    Santi, Daniele
    Esteves, Sandro C.
    Andersen, Claus Yding
    Humaidan, Peter
    Chiodini, Paolo
    De Placido, Giuseppe
    Simoni, Manuela
    [J]. HUMAN REPRODUCTION UPDATE, 2018, 24 (05) : 599 - 614
  • [4] In Estimated Good Prognosis Patients Could Unexpected "Hyporesponse" to Controlled Ovarian Stimulation be Related to Genetic Polymorphisms of FSH Receptor?
    Alviggi, Carlo
    Conforti, Alessandro
    Caprio, Francesca
    Gizzo, Salvatore
    Noventa, Marco
    Strina, Ida
    Pagano, Tiziana
    De Rosa, Pasquale
    Carbone, Floriana
    Colacurci, Nicola
    De Placido, Giuseppe
    [J]. REPRODUCTIVE SCIENCES, 2016, 23 (08) : 1103 - 1108
  • [5] A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept
    Alviggi, Carlo
    Andersen, Claus Y.
    Buehler, Klaus
    Conforti, Alessandro
    De Placido, Giuseppe
    Esteves, Sandro C.
    Fischer, Robert
    Galliano, Daniela
    Polyzos, Nikolaos P.
    Sunkara, Sesh K.
    Ubaldi, Filippo M.
    Humaidan, Peter
    [J]. FERTILITY AND STERILITY, 2016, 105 (06) : 1452 - 1453
  • [6] Association between intrafollicular concentration of benzene and outcome of controlled ovarian stimulation in IVF/ICSI cycles: a pilot study
    Alviggi, Carlo
    Guadagni, Rossella
    Conforti, Alessandro
    Coppola, Giuseppe
    Picarelli, Silvia
    De Rosa, Pasquale
    Vallone, Roberta
    Strina, Ida
    Pagano, Tiziana
    Mollo, Antonio
    Acampora, Antonio
    De Placido, Giuseppe
    [J]. JOURNAL OF OVARIAN RESEARCH, 2014, 7
  • [7] Regimen of ovarian stimulation affects oocyte and therefore embryo quality
    Bosch, Ernesto
    Labarta, Elena
    Kolibianakis, Efstratios
    Rosen, Mitchell
    Meldrum, David
    [J]. FERTILITY AND STERILITY, 2016, 105 (03) : 560 - 570
  • [8] Cohen J, 2017, MINERVA GINECOL, V69, P315, DOI 10.23736/S0026-4784.16.04003-X
  • [9] Novel approaches for diagnosis and management of low prognosis patients in assisted reproductive technology: the POSEIDON concept
    Conforti, Alessandro
    Esteves, Sandro C.
    Picarelli, Silvia
    Iorio, Giuseppe
    Rania, Erika
    Zullo, Fulvio
    De Placido, Giuseppe
    Alviggi, Carlo
    [J]. PANMINERVA MEDICA, 2019, 61 (01) : 24 - 29
  • [10] Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria-The Why
    Esteves, Sandro C.
    Roque, Matheus
    Bedoschi, Giuliano M.
    Conforti, Alessandro
    Humaidan, Peter
    Alviggi, Carlo
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2018, 9